Showing 201 - 220 results of 30,299 for search '(( 10 ng decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (mean decrease)))) ))', query time: 0.76s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206

    rVλ6Wil fibrils cause a decrease in cardiomyocytes MTT reduction without inducing cell death. by Helen P. McWilliams-Koeppen (116503)

    Published 2015
    “…(C) Cell number, quantified using crystal violet (black) did not decrease over 72 h of incubation with 1 μM rVλ6Wil fibrils despite a decrease in MMT reduction (grey; n = 3 samples per time point). …”
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

    Published 2019
    “…After 4 weeks, when the tumor size was approximately 100 mm<sup>3</sup> (T<sub>0</sub>) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”
  12. 212

    Flow diagram of the study. by Yoonjee Cho (15453454)

    Published 2023
    “…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
  13. 213

    Baseline characteristics of patients. by Yoonjee Cho (15453454)

    Published 2023
    “…A total of 162 patients were included. The SOFA score on POD 5 was significantly higher in the High-decrease group compared with the Low-decrease group (5.2 ± 2.6 vs. 4.1 ± 2.3; mean difference: 1.1, 95% CI: 0.3 to 1.8; P = 0.005). …”
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220